PLDT INC-SPON ADR (PHI) Fundamental Analysis & Valuation

NYSE:PHI • US69344D4088

Current stock price

20.64 USD
+0.17 (+0.83%)
Last:

This PHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. PHI Profitability Analysis

1.1 Basic Checks

  • PHI had positive earnings in the past year.
  • In the past year PHI had a positive cash flow from operations.
  • In the past 5 years PHI has always been profitable.
  • Each year in the past 5 years PHI had a positive operating cash flow.
PHI Yearly Net Income VS EBIT VS OCF VS FCFPHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B 40B 60B 80B

1.2 Ratios

  • PHI has a Return On Assets (4.72%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 23.60%, PHI belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
  • The Return On Invested Capital of PHI (8.80%) is better than 68.18% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PHI is in line with the industry average of 7.50%.
  • The last Return On Invested Capital (8.80%) for PHI is above the 3 year average (8.58%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.72%
ROE 23.6%
ROIC 8.8%
ROA(3y)4.75%
ROA(5y)4.02%
ROE(3y)25.59%
ROE(5y)21.54%
ROIC(3y)8.58%
ROIC(5y)7%
PHI Yearly ROA, ROE, ROICPHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • PHI has a Profit Margin of 13.72%. This is amongst the best in the industry. PHI outperforms 86.36% of its industry peers.
  • PHI's Profit Margin has been stable in the last couple of years.
  • With an excellent Operating Margin value of 25.08%, PHI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PHI has grown nicely.
  • The Gross Margin of PHI (86.80%) is better than 86.36% of its industry peers.
  • In the last couple of years the Gross Margin of PHI has remained more or less at the same level.
Industry RankSector Rank
OM 25.08%
PM (TTM) 13.72%
GM 86.8%
OM growth 3Y131.46%
OM growth 5Y2.7%
PM growth 3Y39.05%
PM growth 5Y0.49%
GM growth 3Y-1.15%
GM growth 5Y-1.05%
PHI Yearly Profit, Operating, Gross MarginsPHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1

2. PHI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PHI is creating value.
  • PHI has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PHI remains at a similar level compared to 5 years ago.
  • PHI has a worse debt/assets ratio than last year.
PHI Yearly Shares OutstandingPHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
PHI Yearly Total Debt VS Total AssetsPHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B

2.2 Solvency

  • Based on the Altman-Z score of 0.87, we must say that PHI is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.87, PHI perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • PHI has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as PHI would need 10.07 years to pay back of all of its debts.
  • PHI's Debt to FCF ratio of 10.07 is on the low side compared to the rest of the industry. PHI is outperformed by 63.64% of its industry peers.
  • PHI has a Debt/Equity ratio of 2.63. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.63, PHI is not doing good in the industry: 77.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.63
Debt/FCF 10.07
Altman-Z 0.87
ROIC/WACC2.87
WACC3.07%
PHI Yearly LT Debt VS Equity VS FCFPHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100B 200B 300B

2.3 Liquidity

  • A Current Ratio of 0.44 indicates that PHI may have some problems paying its short term obligations.
  • PHI's Current ratio of 0.44 is on the low side compared to the rest of the industry. PHI is outperformed by 95.45% of its industry peers.
  • A Quick Ratio of 0.42 indicates that PHI may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.42, PHI is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.42
PHI Yearly Current Assets VS Current LiabilitesPHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

3

3. PHI Growth Analysis

3.1 Past

  • PHI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.58%.
  • The Earnings Per Share has been growing slightly by 5.18% on average over the past years.
  • PHI shows a small growth in Revenue. In the last year, the Revenue has grown by 0.72%.
  • Measured over the past years, PHI shows a small growth in Revenue. The Revenue has been growing by 5.09% on average per year.
EPS 1Y (TTM)6.58%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%16.65%
Revenue 1Y (TTM)0.72%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%-1.41%

3.2 Future

  • Based on estimates for the next years, PHI will show a small growth in Earnings Per Share. The EPS will grow by 4.12% on average per year.
  • Based on estimates for the next years, PHI will show a small growth in Revenue. The Revenue will grow by 2.16% on average per year.
EPS Next Y-1.81%
EPS Next 2Y0.24%
EPS Next 3Y1.36%
EPS Next 5Y4.12%
Revenue Next Year1.42%
Revenue Next 2Y1.77%
Revenue Next 3Y2.04%
Revenue Next 5Y2.16%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PHI Yearly Revenue VS EstimatesPHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50B 100B 150B 200B
PHI Yearly EPS VS EstimatesPHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50 100 150

8

4. PHI Valuation Analysis

4.1 Price/Earnings Ratio

  • PHI is valuated cheaply with a Price/Earnings ratio of 7.67.
  • Based on the Price/Earnings ratio, PHI is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.18. PHI is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 7.64, the valuation of PHI can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PHI indicates a rather cheap valuation: PHI is cheaper than 81.82% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 37.96. PHI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.67
Fwd PE 7.64
PHI Price Earnings VS Forward Price EarningsPHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHI indicates a rather cheap valuation: PHI is cheaper than 81.82% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, PHI is valued cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.53
EV/EBITDA 5.36
PHI Per share dataPHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • PHI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.48
EPS Next 2Y0.24%
EPS Next 3Y1.36%

6

5. PHI Dividend Analysis

5.1 Amount

  • PHI has a Yearly Dividend Yield of 7.23%, which is a nice return.
  • PHI's Dividend Yield is a higher than the industry average which is at 6.14.
  • PHI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 7.23%

5.2 History

  • The dividend of PHI has a limited annual growth rate of 3.96%.
  • PHI has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.96%
Div Incr Years0
Div Non Decr Years0
PHI Yearly Dividends per sharePHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 68.74% of the earnings are spent on dividend by PHI. This is not a sustainable payout ratio.
  • PHI's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP68.74%
EPS Next 2Y0.24%
EPS Next 3Y1.36%
PHI Yearly Income VS Free CF VS DividendPHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B -20B 30B
PHI Dividend Payout.PHI Dividend Payout, showing the Payout Ratio.PHI Dividend Payout.PayoutRetained Earnings

PHI Fundamentals: All Metrics, Ratios and Statistics

PLDT INC-SPON ADR

NYSE:PHI (4/14/2026, 3:56:00 PM)

20.64

+0.17 (+0.83%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners5.3%
Inst Owner Change-0.4%
Ins Owners0.81%
Ins Owner Change0%
Market Cap4.46B
Revenue(TTM)218.39B
Net Income(TTM)29.95B
Analysts82.5
Price Target27.21 (31.83%)
Short Float %0.17%
Short Ratio1.28
Dividend
Industry RankSector Rank
Dividend Yield 7.23%
Yearly Dividend1.59
Dividend Growth(5Y)3.96%
DP68.74%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-25
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.6%
PT rev (3m)-3.15%
EPS NQ rev (1m)-3.82%
EPS NQ rev (3m)1.02%
EPS NY rev (1m)-1.25%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 7.67
Fwd PE 7.64
P/S 1.23
P/FCF 7.53
P/OCF 2.72
P/B 2.12
P/tB 4.3
EV/EBITDA 5.36
EPS(TTM)2.69
EY13.03%
EPS(NY)2.7
Fwd EY13.08%
FCF(TTM)2.74
FCFY13.28%
OCF(TTM)7.59
OCFY36.77%
SpS16.79
BVpS9.75
TBVpS4.8
PEG (NY)N/A
PEG (5Y)1.48
Graham Number24.3
Profitability
Industry RankSector Rank
ROA 4.72%
ROE 23.6%
ROCE 11.52%
ROIC 8.8%
ROICexc 9.03%
ROICexgc 10.49%
OM 25.08%
PM (TTM) 13.72%
GM 86.8%
FCFM 16.33%
ROA(3y)4.75%
ROA(5y)4.02%
ROE(3y)25.59%
ROE(5y)21.54%
ROIC(3y)8.58%
ROIC(5y)7%
ROICexc(3y)8.85%
ROICexc(5y)7.45%
ROICexgc(3y)10.42%
ROICexgc(5y)8.87%
ROCE(3y)11.23%
ROCE(5y)9.16%
ROICexgc growth 3Y111.98%
ROICexgc growth 5Y-3.02%
ROICexc growth 3Y115.78%
ROICexc growth 5Y-1.38%
OM growth 3Y131.46%
OM growth 5Y2.7%
PM growth 3Y39.05%
PM growth 5Y0.49%
GM growth 3Y-1.15%
GM growth 5Y-1.05%
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 2.63
Debt/FCF 10.07
Debt/EBITDA 2.92
Cap/Depr 106.04%
Cap/Sales 28.88%
Interest Coverage 4.14
Cash Conversion 86.41%
Profit Quality 119.05%
Current Ratio 0.44
Quick Ratio 0.42
Altman-Z 0.87
F-Score4
WACC3.07%
ROIC/WACC2.87
Cap/Depr(3y)120.38%
Cap/Depr(5y)129.36%
Cap/Sales(3y)32.52%
Cap/Sales(5y)39.68%
Profit Quality(3y)62.78%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.58%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%16.65%
EPS Next Y-1.81%
EPS Next 2Y0.24%
EPS Next 3Y1.36%
EPS Next 5Y4.12%
Revenue 1Y (TTM)0.72%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%-1.41%
Revenue Next Year1.42%
Revenue Next 2Y1.77%
Revenue Next 3Y2.04%
Revenue Next 5Y2.16%
EBIT growth 1Y3.71%
EBIT growth 3Y136.64%
EBIT growth 5Y6.63%
EBIT Next Year104.64%
EBIT Next 3Y30.12%
EBIT Next 5YN/A
FCF growth 1Y165.21%
FCF growth 3YN/A
FCF growth 5Y38.58%
OCF growth 1Y20.81%
OCF growth 3Y9.02%
OCF growth 5Y3.02%

PLDT INC-SPON ADR / PHI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PLDT INC-SPON ADR?

ChartMill assigns a fundamental rating of 5 / 10 to PHI.


What is the valuation status for PHI stock?

ChartMill assigns a valuation rating of 8 / 10 to PLDT INC-SPON ADR (PHI). This can be considered as Undervalued.


Can you provide the profitability details for PLDT INC-SPON ADR?

PLDT INC-SPON ADR (PHI) has a profitability rating of 8 / 10.


How financially healthy is PLDT INC-SPON ADR?

The financial health rating of PLDT INC-SPON ADR (PHI) is 1 / 10.


What is the expected EPS growth for PLDT INC-SPON ADR (PHI) stock?

The Earnings per Share (EPS) of PLDT INC-SPON ADR (PHI) is expected to decline by -1.81% in the next year.